1NCE Wins at the 2024 SaaS Awards
1NCE, a company offering a software platform for connected products, has won the award for “Best SaaS Innovation in the Internet of Things (IoT)” at the SaaS Awards.
The SaaS Awards recognize the leading innovations and applications of software-as-a-service solutions across a wide range of use cases and sectors. The program also named 1NCE a finalist in the “Best SaaS Newcomer” category.
1NCE’s novel proposition – transforming connectivity into a component within software – radically simplifies the supply chain of connectivity for companies across nearly every industry.Since evolving into software in 2022, 1NCE has become a fast-growing global standard in IoT, delivering tools to transform data into actionable insights with minimal effort. 1NCE customers can accelerate time-to-market for IoT projects by months, determine device location without GPS, and optimize transmission to increase battery life by up to 70 percent.
Rakesh Datta, Lead Judge said: “The SaaS Awards team thought it incredible to see how 1NCE has designed an IoT connectivity solution that caters to the two critical aspects of minimal power consumption as well as bandwidth usage. Their fixed-cost model combined with ease of global scalability are a mix rarely seen in the IoT space. Great customer feedback, great product in the IoT connectivity space. Congratulations 1NCE!”
New customers can get started today at the 1NCE online shop. Support is available in 25 languages.
About 1NCE
1NCE is a company offering a software platform for connected products that delivers future-proof, hassle-free IoT in 173 countries and regions. The software platform enables customers to easily, securely and reliably collect device data and turn it into actionable intelligence. This accelerates time-to-market for data collection projects by months, increases device lifetime by years, and allows efficient management of sensors from initial deployment to the end of the product lifecycle. More than 20,000 customers -- including 60 Fortune 500 companies -- trust 1NCE with 22 million connected products. Learn more at www.1NCE.com and follow on Facebook, LinkedIn and Twitter/X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240822153793/en/
Contacts
Brad Chase // brad.chase@1NCE.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s CDK2 Inhibitor INCB123667 Shows Promising Evidence of Clinical Activity in Patients with Advanced Solid Tumors, Notably Ovarian Cancer14.9.2024 18:45:00 CEST | Press release
Incyte (Nasdaq:INCY) today announced new early clinical data for INCB123667, a highly selective, potential first-in-class CDK2 inhibitor, in patients with advanced solid tumors. The trial results, presented during a mini-oral presentation at the European Society of Medical Oncology (ESMO) with new, updated data shared during the Company’s investor event, highlight the potential of INCB123667 as a differentiated treatment option for cancers with increased Cyclin E1 activity, amplification and/or overexpression in cells predictive of CDK2 dependency. In the trial, patients with advanced or metastatic solid tumors (n=205) – including ovarian cancer, endometrial cancer, gastrointestinal cancer, HR+/HER2- breast cancer and triple negative breast cancer, among others – received varying doses of INCB123667 ranging from 50mg to 150mg using once-daily (QD) and twice-daily (BID) dosing schedules. New data from the Phase 1b dose expansion portion of the trial (data cut-off August 26, 2024) presen
Incyte’s Retifanlimab (Zynyz ® ) Extends Progression-Free Survival in Patients with Squamous Cell Anal Carcinoma (SCAC); Data Featured at ESMO 2024 Presidential Symposium14.9.2024 16:30:00 CEST | Press release
Incyte (Nasdaq:INCY) today announced results from the Phase 3 POD1UM-303/InterAACT2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with platinum-based chemotherapy (carboplatin–paclitaxel) for the treatment of adults with inoperable locally recurrent or metastatic squamous cell anal carcinoma (SCAC). These data were featured today in a Presidential Symposium (LBA 2) at the European Society for Medical Oncology (ESMO) Congress 2024, held in Barcelona and virtually. The POD1UM-303/InterAACT2 trial results build on previously announced topline results, showing that the study met its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) in patients with SCAC not previously treated with systemic therapy, as assessed by blinded independent central review (BICR) using RECIST v1.1. Adding retifanlimab to standard of care chemotherapy res
Irdeto Partners with Bitmovin to Deliver Industry-Leading Secure Low-Latency Streaming with Unmatched User Experience14.9.2024 10:00:00 CEST | Press release
Irdeto, the global leader in digital video platform experiences and security, and Bitmovin, the industry leader in video software solutions, today announced a strategic partnership to deliver enhanced secure video streaming experiences. This collaboration integrates Bitmovin’s renowned Player and Analytics suite into Irdeto Experience, the award-winning streaming platform trusted by top-tier operators worldwide. Together, they will provide streaming service providers, content owners, and pay-TV operators with cutting-edge solutions that address the critical need for low-latency streaming. The combination of Irdeto’s expertise in security and Bitmovin’s preeminent player offers a powerful and comprehensive solution. This joint offering allows operators to benefit from smooth, high-resolution streaming and advanced advertising and security features. The collaboration also enables operators to extend device reach by covering a wider range of devices in the Smart TV market. Whether for liv
SCF Acquires Newpark Fluids Systems14.9.2024 02:40:00 CEST | Press release
SCF Partners, Inc. (“SCF”) is pleased to announce its acquisition of the Newpark Fluids Systems business (“NFS”), a leading global pure-play oil & gas and geothermal fluids solution provider, from Newpark Resources Inc. (NYSE: NR). Newpark Fluids Systems provides a full range of drilling & completion products and related technical services supported by an innovative digital modeling software suite, global supply chain and infrastructure to enhance the efficiency and productivity of our customers’ performance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240913427560/en/ Newpark Fluid Systems’ CEO, David Paterson, commented, “We are thrilled to partner with SCF. This new partnership will be a source of enormous value creation for both our customers and the entire Newpark Fluids Systems team. Our global strategic growth plan will now accelerate under a new and focused board with significant energy experience and commitment.
Important Looking Pirates Wins Its Third Creative Arts Emmy Award for Its Work on the FX Series Shōgun13.9.2024 18:00:00 CEST | Press release
Philip Engström, VFX Supervisor and Chelsea Mirus, VFX Production Manager represented Important Looking Pirates (“ILP”) on the Shōgun ballot at the award ceremony in Los Angeles, winning the Emmy in the Special Visual Effects In A Season Or A Movie category. ILP had the honour of contributing to 7 out of the 10 episodes for the FX series, which was led by overall VFX supervisor Michael Cliett, and won a record-breaking 14 Creative Arts Emmy awards and is poised to extend that streak at the Primetime Emmys later this week. With an emphasis on historical authenticity, ILP was responsible for large-scale full CG environments, vast crowd work, a devastating landslide and sweeping marine simulations. In addition to Shōgun, ILP was recognized with nominations for 2 of the remaining 4 visual effects nominees at this year’s awards: Netflix’s Avatar: The Last Airbender with Niklas Jacobson as VFX Supervisor and Amazon’s Fallout with Ahmed Gharraph as VFX Supervisor. Additionally, the studio was
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom